Skip to main content
Equibles

Clearstead Advisors, LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 842775 CLEVELAND, OH
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$81,176
+$74,686 QoQ
Shares Held
5,610
+819.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#97
of 136 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Clearstead Advisors, LLC holds $25,889,505 across 201 Biotechnology names. DSGN ranks #26 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VIR
Vir Biotechnology, Inc.
 608,234 $6,197,904
2 TWST
Twist Bioscience Corp
 37,624 $3,870,757
3 IBRX
ImmunityBio, Inc.
 341,711 $2,991,679
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,510 $2,240,252
5 BEAM
Beam Therapeutics Inc.
 60,620 $2,080,478
6 NAUT
Nautilus Biotechnology, Inc.
 892,787 $1,669,511
7 SRRK
Scholar Rock Holding Corp
 13,058 $718,190
8 RVMD
Revolution Medicines, Inc.
 3,813 $714,098

All Filings in DSGN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $81,176 5,610
2026-03-31 $6,490 610
2025-12-31 $5,721 610
2025-09-30 $4,593 610
2025-06-30 $2,055 610
2025-03-31 $2,354 610
2024-12-31 $3,763 610
2024-09-30 $3,281 610
2024-06-30 $2,043 610
2024-03-31 $2,458 610
2023-12-31 $1,616 610
2023-09-30 $1,439 610
2023-06-30 $3,843 610
2023-03-31 $3,519 610